临床儿科杂志 ›› 2024, Vol. 42 ›› Issue (1): 63-69.doi: 10.12372/jcp.2024.22e0590

• 论著 • 上一篇    下一篇

儿童幽门螺杆菌三联疗法根除疗效及影响因素分析

耿甜, 余仲苏, 周西西, 刘波, 张慧华, 李中跃()   

  1. 重庆医科大学附属儿童医院消化科 国家儿童健康与疾病临床医学研究中心 儿童发育疾病研究教育部重点实验室 儿童发育重大疾病国家国际科技合作基地 儿科学重庆市重点实验室(重庆 400014
  • 收稿日期:2022-04-26 出版日期:2024-01-15 发布日期:2024-01-05
  • 通讯作者: 李中跃 E-mail:lizhongyue1001@hotmail.com
  • 基金资助:
    重庆市科卫联合医学科研项目(2019ZDXM045)

Analysis of eradication effect and influencing factors of triple therapy of Helicobacter pylori in children

GENG Tian, YU Zhongsu, ZHOU Xixi, LIU Bo, ZHANG Huihua, LI Zhongyue()   

  1. Department of Gastroenterology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
  • Received:2022-04-26 Online:2024-01-15 Published:2024-01-05
  • Contact: LI Zhongyue E-mail:lizhongyue1001@hotmail.com

摘要:

目的 探索重庆地区儿童幽门螺杆菌(H.pylori)三联疗法根除疗效及影响因素。方法 收集消化科门诊就诊的156例疑似H.pylori感染儿童的胃黏膜标本,进行H.pylori培养、药敏试验和基因检测。H.pylori感染诊断明确的患儿接受三联疗法根除治疗,计算三联疗法根除率并分析疗效的影响因素。结果 156例疑似H.pylori感染儿童中符合H.pylori诊断标准的有138例,其中109例接受14天的标准三联方案(奥美拉唑+阿莫西林+克拉霉素)根除治疗,男53例、女56例,平均年龄(9.6±3.0)岁,最终64例(58.7%)根除成功。95例患儿H.pylori培养阳性,克拉霉素敏感株根除率81.6%(40/49)显著高于耐药株34.8%(16/46),差异有统计学意义(P<0.01)。95例患儿中87例行基因检测,根据基因检测结果克拉霉素敏感株根除率为76.2%(32/42),显著高于耐药株42.2%(19/45),差异有统计学意义(P<0.01)。患儿性别、年龄、内镜诊断、黏膜组织病理炎症程度、CYP2C19基因多态性、毒力基因vacAcagA与标准三联方案根除率无关(P>0.05)。结论 标准三联疗法不适合重庆地区儿童H.pylori治疗,以药敏试验为基础的个体化治疗方案是更好的选择。

关键词: 幽门螺杆菌, 三联疗法, 儿童

Abstract:

Objective To explore the eradication effect and influencing factors of triple therapy of Helicobacter pylori (H.pylori) in children from Chongqing. Methods Gastric mucosa samples were collected from 156 children with suspected H.pylori infection who visited the gastroenterology clinic. H.pylori culture, drug susceptibility test and gene detection were performed. Children diagnosed with H.pylori infection received triple therapy eradication. The eradication rate of triple therapy was calculated and the influencing factors of efficacy were analyzed. Results Among 156 children with suspected H.pylori infection, 138 met the diagnostic criteria for H.pylori infection. Among them, 109 children (53 boys and 56 girls) were treated with standard triple therapy (omeprazole + amoxicillin + clarithromycin) for 14 days, with an average age of (9.6±3.0) years, and 64 (58.7%) were successfully eradicated from H.pylori infection. The eradication rate of clarithromycin sensitive strain was 81.6% (40/49), which was significantly higher than that of drug-resistant strain (34.8%, 16/46), the difference was statistically significant (P<0.01). Of the 95 children, 87 underwent genetic testing. The eradication rate of clarithromycin sensitive strains was 76.2% (32/42), which was significantly higher than that of drug-resistant strains (42.2%, 19/45), and the difference was statistically significant (P<0.01). Gender, age, endoscopic diagnosis, histopathological appearance of mucosal tissue based on severity of inflammation, CYP2C19 gene polymorphism, vacA and cagA virulence genes were not correlated with the eradication rate of standard triple regimen (P>0.05). Conclusions Standard triple therapy is not suitable for the eradication of H.pylori in children in Chongqing area, and individualized treatment based on drug sensitivity test is a better choice.

Key words: Helicobacter pylori, triple therapy, child